WIN Consortium  WIN 联合会 www.winconsortium.org 
WIN 联合会由得克萨斯大学MD Anderson癌症中心（美国）和Gustave Roussy研究所（法国）于2010年发起，是学术界、制药、生物技术、健康保健IT和患者权益领域29家领先组织的全球性网络，旨在通过世界各地的临床试验和研究课题，开发、应用基于基因组的癌症研究中最具前景的进展，加快抗癌新药向临床转化的步伐、降低成本。WIN是非政府、非营利组织，总部设在巴黎。
 
Initiated in 2010 by the University of Texas MD Anderson Cancer Center (USA) and the Institut Gustave Roussy (France), the WIN Consortium is a global network of 29 leading organizations from the academic, pharmaceutical, biotechnology, healthcare IT, and patient advocacy sectors working to accelerate the pace and reduce the cost of translating novel cancer treatments to the bedside by developing and applying, through worldwide clinical trials and research projects, the most promising advances in genomic-based cancer research. WIN is a non-governmental, not-for-profit organization headquartered in Paris.